The term cirrhosis-associated immune dysfunction (CAID) comprises the distinctive
spectrum of immune alterations associated with the course of end-stage liver disease …

It has been reported that corticosteroid therapy was effective in the management of severe
acute respiratory syndrome (SARS) and the Middle East Respiratory Syndrome (MERS) …

Background The clinical presentation of COVID‐19 ranges from a mild, self‐limiting disease,
to multiple organ failure and death. Most severe COVID‐19 cases present low lymphocytes …

Background & Aims In alcohol-associated hepatitis (AH), inflammation and neutrophil counts
correlate with poor clinical outcomes. Here, we investigated how neutrophils contribute to …

Background Early identification of patients who are at high risk of poor clinical outcomes is of
great importance in saving the lives of patients with novel coronavirus disease 2019 (COVID …

Background The vast impact of COVID-19 call for the identification of clinical parameter that
can help predict a torpid evolution. Among these, endothelial injury has been proposed as …

Alcohol‐associated liver disease (ALD) is emerging worldwide as the leading cause of liver‐
related morbidity, mortality, and indication for liver transplantation. The ALD Special Interest …

Inflammatory bowel diseases (IBD) encompass two main entities including ulcerative colitis
and Crohn's disease. Although having a common global pathophysiological mechanism …

Alcohol-related liver disease is a major cause of liver disease-associated mortality, with
inpatient care being a major contributor to its clinical and economic burden. Alcohol-related …

Infection by SARS-CoV2 has devastating consequences on health care systems. It is a
global health priority to identify patients at risk of fatal outcomes. 1955 patients admitted to …